Stock UniverseDerived research view · source repositories remain read-only

TG Therapeutics, Inc. (TGTX)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Qualified
Selection Score
39.39
Global Rank
491
Market Cap
4.40B
Latest Close
40.16
RS Composite
19.62% · G#467

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-4.31%
3M
37.21%
6M
27.05%
1Y
8.44%
3Y
50.81%
5Y
15.17%
10Y
434.04%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.75M · 30-day average: 2.07M · Max drawdown over stored range: -93.19%

Research Snapshot

Relative Strength vs SPX

RS Composite19.62%
20D RS-7.29%
60D RS34.20%
120D RS18.50%
Global RS Rank467 · 86.08% percentile
Qualified+ RS Rank187 · 85.14% percentile
Group ScopeQualified+
Primary RS Rank69 · 84.93% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank55 / 701
Primary Percentile92.30
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-06700.35Mn/a149.50M461.90M2.87-63.95M332.00K-64.28M161Mn/a21.35%65.95%-9.13%-9.18%514.43M745.14M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$2.8714.0x$4.369.2x$-0.40-100.4x$-0.40-101.0x

Shares Diluted: 161M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue0.1526.6892.785233.662329.004616.287
Revenue Growth (YoY)3800%4300.658%-58.364%8290.018%40.803%87.319%
Gross Profit0.1525.8992.52219.531290.518515.573
Operating Income-273.594-344.77-218.31620.63341.929123.324
Free Cash Flow-214.864-296.035-176.184-31.413-40.562-24.986
Free Cash Flow Per Share-1.863-2.239-1.301-0.212-0.253-0.15479570615817417
EPS (Diluted) GAAP-2.422371-2.632686-1.6528310.0892670.152.769999
EPS Growth3800%3800%3800%3800%68.035%1746.666%
EPS Non-GAAP
Gross Margin100%88.19%90.485%93.952%88.302%83.658%
Operating Margin-179996.053%-5154.283%-7838.995%8.83%12.744%20.011%
Profit Margin-183803.289%-5204.081%-8036.338%5.423%7.107%72.56%
Free Cash Flow Margin-141357.895%-4425.699%-6326.176%-13.444%-12.329%-4.0543%
Shares Outstanding (Diluted)115.3337132.2228135.4113148.5085160.3361161.4127
Shares Change (YoY)30.514%14.644%2.411%9.672%7.964%0.672%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-06204.92Mn/a34.80M16.98%19.78M9.65%0.12160.06M514.43M745.14Mprocessed
2025 Q42026-02-27192.57Mn/a50.49M26.22%23.04M11.96%0.14159.34M141.97M245.65Mprocessed
2025 Q32025-11-05161.71Mn/a29.36M18.16%390.89M2.42%2.43161.00M131.58M245.34Mprocessed
2025 Q22025-08-08141.15Mn/a34.84M24.69%28.19M19.97%0.17162.56M251.87M245.04Mprocessed
2025 Q12025-05-09120.86Mn/a8.62M7.13%5.06M4.19%0.03162.77M276.24M244.73Mprocessed
2024 Q42025-03-03108.19Mn/a29.95M27.68%23.33M21.57%0.15160.24M311.00M244.43Mprocessed
2024 Q32024-11-0783.88Mn/a12.43M14.82%3.88M4.63%0.02160.71M341.04M244.16Mprocessed
2024 Q22024-08-0973.47Mn/a8.82M12.00%6.88M9.36%0.04159.42M217.25M102.54Mprocessed
2024 Q12024-05-0663.47Mn/a-9.27M-14.60%-10.71M-16.87%n/an/a209.78M101.33Mprocessed
2023 Q42024-02-2943.97Mn/a-12.48M-28.39%-14.42M-32.79%-0.09156.18M217.51M100.12Mprocessed
2023 Q32023-11-06165.81Mn/a114.78M69.22%113.93M68.71%0.73155.87M229.16M98.91Mprocessed
2023 Q22023-08-0416.07Mn/a-44.67M-2.78%n/an/a-0.34141.50M144.91M97.70Mprocessed
2023 Q12023-05-087.80Mn/a-36.99M-4.74%n/an/a-0.28140.31M139.71M96.50Mprocessed
2022 Q42023-03-0180.00Kn/a-52.06M-650.77%n/an/an/a137.13M161.68M71.14Mprocessed
2022 Q32022-11-0994.00Kn/a-34.96M-371.95%n/an/a-0.26135.33M175.94M70.04Mprocessed
2022 Q22022-08-09594.00Kn/a-38.94M-65.56%n/an/a-0.30134.78M195.71M68.95Mprocessed
2022 Q12022-05-102.02Mn/a-66.87M-33.17%n/an/a-0.51134.40M233.20M67.25Mprocessed
2021 Q42022-03-012.32Mn/a-92.95M-40.05%n/an/an/an/a314.76M66.79Mprocessed
2021 Q32021-11-082.03Mn/a-85.13M-41.93%n/an/an/an/a356.85M30.59Mprocessed
2021 Q22021-08-061.54Mn/a-77.49M-50.16%n/an/an/an/a443.46M30.36Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.